ATE122236T1 - Vorläufer des hüllenglykoproteins des hiv-2 retrovirus und verwandte antigene. - Google Patents

Vorläufer des hüllenglykoproteins des hiv-2 retrovirus und verwandte antigene.

Info

Publication number
ATE122236T1
ATE122236T1 AT89401617T AT89401617T ATE122236T1 AT E122236 T1 ATE122236 T1 AT E122236T1 AT 89401617 T AT89401617 T AT 89401617T AT 89401617 T AT89401617 T AT 89401617T AT E122236 T1 ATE122236 T1 AT E122236T1
Authority
AT
Austria
Prior art keywords
retrovirus
hiv
precursor
envelope glycoprotein
protein
Prior art date
Application number
AT89401617T
Other languages
English (en)
Inventor
Luc Montagnier
Ara Hovanessian
Anne Laurent
Bernard Krust
Marie-Anne Rey
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8807817A external-priority patent/FR2632644B1/fr
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE122236T1 publication Critical patent/ATE122236T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
AT89401617T 1988-06-09 1989-06-09 Vorläufer des hüllenglykoproteins des hiv-2 retrovirus und verwandte antigene. ATE122236T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20434688A 1988-06-09 1988-06-09
FR8807817A FR2632644B1 (fr) 1988-06-10 1988-06-10 Antigenes precurseurs des glycoproteines d'enveloppe d'un retrovirus humain hiv-2 et antigenes presentant une parente immunologique avec ces derniers. preparation de ces antigenes. application au diagnostic

Publications (1)

Publication Number Publication Date
ATE122236T1 true ATE122236T1 (de) 1995-05-15

Family

ID=26226719

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89401617T ATE122236T1 (de) 1988-06-09 1989-06-09 Vorläufer des hüllenglykoproteins des hiv-2 retrovirus und verwandte antigene.

Country Status (9)

Country Link
EP (1) EP0354072B1 (de)
JP (1) JP3093763B2 (de)
AT (1) ATE122236T1 (de)
CA (1) CA1341488C (de)
DE (1) DE68922540T2 (de)
DK (1) DK175668B1 (de)
ES (1) ES2074085T3 (de)
HK (1) HK167295A (de)
PT (1) PT90800B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005078443A1 (en) * 2004-02-13 2005-08-25 Inverness Medical Switzerland Gmbh Determination of infection by the immune response to a carbohydrate moiety

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0249611A4 (de) * 1985-11-14 1988-04-26 Harvard College T-lymphotrophisches virus.
EP0269520A3 (de) * 1986-11-21 1988-08-24 Institut Pasteur Zum Hervorrufen von AIDS geeignetes Retrovirus vom HIV-2-Typ sowie seine Antigen- und Nukleinsäurebestandteile
EP0283327B1 (de) * 1987-01-16 1997-06-25 Institut Pasteur Peptide mit den immunologischen Eigenschaften von HIV-2

Also Published As

Publication number Publication date
EP0354072A1 (de) 1990-02-07
PT90800A (pt) 1989-12-29
DE68922540D1 (de) 1995-06-14
CA1341488C (fr) 2005-08-30
DK284389A (da) 1989-12-10
DK175668B1 (da) 2005-01-10
DE68922540T2 (de) 1995-10-05
JP3093763B2 (ja) 2000-10-03
JPH02119791A (ja) 1990-05-07
ES2074085T3 (es) 1995-09-01
DK284389D0 (da) 1989-06-09
HK167295A (en) 1995-11-03
EP0354072B1 (de) 1995-05-10
PT90800B (pt) 1994-11-30

Similar Documents

Publication Publication Date Title
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
MY136081A (en) Modified hiv - 1gag p17 peptide and immunogenic composition
DK513388D0 (da) Peptider med immunologiske egenskaber svarende til hiv-2 virus, nucleotidsekvenser, der koder for saadanne peptider, antigene og immunogene midler indeholdende saadanne peptider samt fremgangsmaade og kit til in vitro diagnose af hiv-2
ATE64601T1 (de) Lymphadenopathie-assoziierte huellenantigene und deren verwendungen.
DE60039036D1 (de) Hiv-peptide, antigene und impfstoffzusammensetzungen
CY1107570T1 (el) Ανοσογονικα πολυπεπτιδια κωδικοποιουμενα απο μινιγονιδια mage και οι χρησεις τους
JP2001527029A5 (de)
EP0429477A4 (en) Synthetic vaccine against aids virus
NO20025153L (no) Fremgangsmåter og sammensetninger for å påvirke formering av HIV-1, HIV-2 og SIV
DE3855134D1 (de) Monoklonale menschliche antikörper gegen hiv-i
FI885296A0 (fi) Rekombinant hiv-2 polypeptid.
ATE122236T1 (de) Vorläufer des hüllenglykoproteins des hiv-2 retrovirus und verwandte antigene.
NZ220500A (en) Recombinant felv polypeptide; vaccine and expression vectors
DK0439601T3 (da) Præparat indeholdende en B-epitop fra kappe- glycoproteinet fra et retrovirus og en T-epitop fra et protein, der er forskelligt fra dette retrovirus
ATE247485T1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
US20030099934A1 (en) Chemically modified hiv envelope glycoprotein
ATE136789T1 (de) Antigene eines transmembranen hüllenglycoproteins eines menschlichen retrovirus des typs hiv-2 und immunologisch verwandte antigene
PT86752A (pt) Procede pour la preparation de peptides susceptibles d:etre reconnus par des anticorps induits contre des retrovirus d:immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et le cas echeant a la vaccination contre le sida

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time